APA

Le Brun P. P. H., de Boer A. H., Mannes G. P. M., de Fraîture D. M. I., Brimicombe R. W., Touw D. J., Vinks A. A., Frijlink H. W. & Heijerman H. G. M. (20021226). Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. : European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Chicago

Le Brun P P H, de Boer A H, Mannes G P M, de Fraîture D M I, Brimicombe R W, Touw D J, Vinks A A, Frijlink H W and Heijerman H G M. 20021226. Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. : European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Harvard

Le Brun P. P. H., de Boer A. H., Mannes G. P. M., de Fraîture D. M. I., Brimicombe R. W., Touw D. J., Vinks A. A., Frijlink H. W. and Heijerman H. G. M. (20021226). Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. : European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

MLA

Le Brun P P H, de Boer A H, Mannes G P M, de Fraîture D M I, Brimicombe R W, Touw D J, Vinks A A, Frijlink H W and Heijerman H G M. Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. : European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 20021226.